Enrique Galicia | Future Pharma Europe

Day 2 | 21th October

10:00 AM Case Study: From Activity to Impact: How to redesign commercial excellence and field force effectiveness for the omnichannel era

How can commercial excellence evolve from operational coordination to a strategic capability that improves execution quality, HCP engagement and business impact?
How can field force effectiveness move beyond activity tracking to focus on engagement quality, customer outcomes and measurable impact?
How can CRM, segmentation, analytics and field insights enable smarter prioritisation, stronger local execution and AI-ready commercial decision-making?

2:35 PM Crystal Ball Fireside Chat & Polling: What is the future of pharma engagement: hype, hope or hard reality?

AI promises transformation, omnichannel promises scale, and data promises insight, but what will truly change pharma engagement over the next ten years? This crystal-ball segment takes a visionary look ahead at what the future for pharma sector in an AI-driven world.

Join leaders as they:

Examine how AI, omnichannel, CRM and customer expectations will reshape pharma engagement and what pharma needs to prioritise now to stay ahead.
Discover which technologies will move from experimentation to business-as-usual
Discuss what will disappear, what will scale, and what will remain stubbornly unchanged
Where pharma leaders should invest now, and where to hold back